Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1818 entries
Sorted by: Best Match Show Resources per page
Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease.

Clinical kidney journal

Vega A, Abad S, Macías N, Aragoncillo I, Santos A, Galán I, Cedeño S, Manuel López-Gómez J.
PMID: 28396734
Clin Kidney J. 2017 Apr;10(2):170-175. doi: 10.1093/ckj/sfw126. Epub 2017 Feb 08.

No abstract available.

Cite
Vega A, Abad S, Macías N, et al. Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clin Kidney J. 2017;10(2):170-175doi: 10.1093/ckj/sfw126.
Vega, A., Abad, S., Macías, N., Aragoncillo, I., Santos, A., Galán, I., Cedeño, S., & Manuel López-Gómez, J. (2017). Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clinical kidney journal, 10(2), 170-175. https://doi.org/10.1093/ckj/sfw126
Vega, Almudena, et al. "Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease." Clinical kidney journal vol. 10,2 (2017): 170-175. doi: https://doi.org/10.1093/ckj/sfw126
Vega A, Abad S, Macías N, Aragoncillo I, Santos A, Galán I, Cedeño S, Manuel López-Gómez J. Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clin Kidney J. 2017 Apr;10(2):170-175. doi: 10.1093/ckj/sfw126. Epub 2017 Feb 08. PMID: 28396734; PMCID: PMC5381238.
Copy Download .nbib Format: NLM
Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy.

Clinical kidney journal

Jullien P, Seitz Polski B, Maillard N, Thibaudin D, Laurent B, Ollier E, Alamartine E, Lambeau G, Mariat C.
PMID: 28396737
Clin Kidney J. 2017 Apr;10(2):209-214. doi: 10.1093/ckj/sfw121. Epub 2017 Feb 20.

No abstract available.

Cite
Jullien P, Seitz Polski B, Maillard N, et al. Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy. Clin Kidney J. 2017;10(2):209-214doi: 10.1093/ckj/sfw121.
Jullien, P., Seitz Polski, B., Maillard, N., Thibaudin, D., Laurent, B., Ollier, E., Alamartine, E., Lambeau, G., & Mariat, C. (2017). Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy. Clinical kidney journal, 10(2), 209-214. https://doi.org/10.1093/ckj/sfw121
Jullien, Perrine, et al. "Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy." Clinical kidney journal vol. 10,2 (2017): 209-214. doi: https://doi.org/10.1093/ckj/sfw121
Jullien P, Seitz Polski B, Maillard N, Thibaudin D, Laurent B, Ollier E, Alamartine E, Lambeau G, Mariat C. Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy. Clin Kidney J. 2017 Apr;10(2):209-214. doi: 10.1093/ckj/sfw121. Epub 2017 Feb 20. PMID: 28396737; PMCID: PMC5381233.
Copy Download .nbib Format: NLM
Renal allograft granulomatous interstitial nephritis: observations of an uncommon injury pattern in 22 transplant recipients.

Clinical kidney journal

Farris AB, Ellis CL, Rogers TE, Chon WJ, Chang A, Meehan SM.
PMID: 28396741
Clin Kidney J. 2017 Apr;10(2):240-248. doi: 10.1093/ckj/sfw117. Epub 2017 Feb 01.

No abstract available.

Cite
Farris AB, Ellis CL, Rogers TE, et al. Renal allograft granulomatous interstitial nephritis: observations of an uncommon injury pattern in 22 transplant recipients. Clin Kidney J. 2017;10(2):240-248doi: 10.1093/ckj/sfw117.
Farris, A. B., Ellis, C. L., Rogers, T. E., Chon, W. J., Chang, A., & Meehan, S. M. (2017). Renal allograft granulomatous interstitial nephritis: observations of an uncommon injury pattern in 22 transplant recipients. Clinical kidney journal, 10(2), 240-248. https://doi.org/10.1093/ckj/sfw117
Farris, Alton B, et al. "Renal allograft granulomatous interstitial nephritis: observations of an uncommon injury pattern in 22 transplant recipients." Clinical kidney journal vol. 10,2 (2017): 240-248. doi: https://doi.org/10.1093/ckj/sfw117
Farris AB, Ellis CL, Rogers TE, Chon WJ, Chang A, Meehan SM. Renal allograft granulomatous interstitial nephritis: observations of an uncommon injury pattern in 22 transplant recipients. Clin Kidney J. 2017 Apr;10(2):240-248. doi: 10.1093/ckj/sfw117. Epub 2017 Feb 01. PMID: 28396741; PMCID: PMC5381240.
Copy Download .nbib Format: NLM
The large spectrum of renal disease in diabetic patients.

Clinical kidney journal

Bermejo S, Pascual J, Soler MJ.
PMID: 28396743
Clin Kidney J. 2017 Apr;10(2):255-256. doi: 10.1093/ckj/sfw137. Epub 2017 Jan 17.

The prevalence of diabetic nephropathy (DN) among diabetic patients seems to be overestimated. Recent studies with renal biopsies show that the incidence of non-diabetic nephropathy (NDN) among diabetic patients is higher than expected. Renal impairment of diabetic patients is...

Cite
Bermejo S, Pascual J, Soler MJ. The large spectrum of renal disease in diabetic patients. Clin Kidney J. 2017;10(2):255-256doi: 10.1093/ckj/sfw137.
Bermejo, S., Pascual, J., & Soler, M. J. (2017). The large spectrum of renal disease in diabetic patients. Clinical kidney journal, 10(2), 255-256. https://doi.org/10.1093/ckj/sfw137
Bermejo, Sheila, et al. "The large spectrum of renal disease in diabetic patients." Clinical kidney journal vol. 10,2 (2017): 255-256. doi: https://doi.org/10.1093/ckj/sfw137
Bermejo S, Pascual J, Soler MJ. The large spectrum of renal disease in diabetic patients. Clin Kidney J. 2017 Apr;10(2):255-256. doi: 10.1093/ckj/sfw137. Epub 2017 Jan 17. PMID: 28396743; PMCID: PMC5381242.
Copy Download .nbib Format: NLM
Optimization of anti-infective dosing regimens during online haemodiafiltration.

Clinical kidney journal

Jager NG, Zandvliet AS, Touw DJ, Penne EL.
PMID: 28396747
Clin Kidney J. 2017 Apr;10(2):282-290. doi: 10.1093/ckj/sfx009. Epub 2017 Mar 29.

Online haemodiafiltration (HDF) is increasingly used in clinical practice as a routine intermittent dialysis modality. It is well known that renal impairment and renal replacement therapy can substantially affect the pharmacokinetic behaviour of several drugs. However, surprisingly few data...

Cite
Jager NG, Zandvliet AS, Touw DJ, et al. Optimization of anti-infective dosing regimens during online haemodiafiltration. Clin Kidney J. 2017;10(2):282-290doi: 10.1093/ckj/sfx009.
Jager, N. G., Zandvliet, A. S., Touw, D. J., & Penne, E. L. (2017). Optimization of anti-infective dosing regimens during online haemodiafiltration. Clinical kidney journal, 10(2), 282-290. https://doi.org/10.1093/ckj/sfx009
Jager, Nynke G L, et al. "Optimization of anti-infective dosing regimens during online haemodiafiltration." Clinical kidney journal vol. 10,2 (2017): 282-290. doi: https://doi.org/10.1093/ckj/sfx009
Jager NG, Zandvliet AS, Touw DJ, Penne EL. Optimization of anti-infective dosing regimens during online haemodiafiltration. Clin Kidney J. 2017 Apr;10(2):282-290. doi: 10.1093/ckj/sfx009. Epub 2017 Mar 29. PMID: 28396747; PMCID: PMC5381234.
Copy Download .nbib Format: NLM
Haematological malignancies and acute kidney injury requiring nephrology consultation: challenging the worst of the worst.

Clinical kidney journal

Chuva T, Maximino J, Barbosa J, Silva S, Paiva A, Baldaia J, Loureiro A.
PMID: 27274827
Clin Kidney J. 2016 Jun;9(3):418-23. doi: 10.1093/ckj/sfw026. Epub 2016 May 04.

BACKGROUND: Acute kidney injury (AKI) often complicates the course of haematological malignancies (HMs) and confers a worse prognosis. The majority of these patients are managed by the attending physician, yet, a small group, mostly coincident with the worst presentation...

Cite
Chuva T, Maximino J, Barbosa J, et al. Haematological malignancies and acute kidney injury requiring nephrology consultation: challenging the worst of the worst. Clin Kidney J. 2016;9(3):418-23doi: 10.1093/ckj/sfw026.
Chuva, T., Maximino, J., Barbosa, J., Silva, S., Paiva, A., Baldaia, J., & Loureiro, A. (2016). Haematological malignancies and acute kidney injury requiring nephrology consultation: challenging the worst of the worst. Clinical kidney journal, 9(3), 418-23. https://doi.org/10.1093/ckj/sfw026
Chuva, Teresa, et al. "Haematological malignancies and acute kidney injury requiring nephrology consultation: challenging the worst of the worst." Clinical kidney journal vol. 9,3 (2016): 418-23. doi: https://doi.org/10.1093/ckj/sfw026
Chuva T, Maximino J, Barbosa J, Silva S, Paiva A, Baldaia J, Loureiro A. Haematological malignancies and acute kidney injury requiring nephrology consultation: challenging the worst of the worst. Clin Kidney J. 2016 Jun;9(3):418-23. doi: 10.1093/ckj/sfw026. Epub 2016 May 04. PMID: 27274827; PMCID: PMC4886918.
Copy Download .nbib Format: NLM
Incident chronic kidney disease: trends in management and outcomes.

Clinical kidney journal

Perkins RM, Chang AR, Wood KE, Coresh J, Matsushita K, Grams M.
PMID: 27274830
Clin Kidney J. 2016 Jun;9(3):432-7. doi: 10.1093/ckj/sfw044. Epub 2016 May 25.

BACKGROUND: Management trends in early chronic kidney disease (CKD) and their associations with clinical outcomes have not previously been reported.METHODS: We evaluated incident (Stage G3A) CKD patients from an integrated health care system in 2004-06, 2007-09 and 2010-12 to...

Cite
Perkins RM, Chang AR, Wood KE, et al. Incident chronic kidney disease: trends in management and outcomes. Clin Kidney J. 2016;9(3):432-7doi: 10.1093/ckj/sfw044.
Perkins, R. M., Chang, A. R., Wood, K. E., Coresh, J., Matsushita, K., & Grams, M. (2016). Incident chronic kidney disease: trends in management and outcomes. Clinical kidney journal, 9(3), 432-7. https://doi.org/10.1093/ckj/sfw044
Perkins, Robert M, et al. "Incident chronic kidney disease: trends in management and outcomes." Clinical kidney journal vol. 9,3 (2016): 432-7. doi: https://doi.org/10.1093/ckj/sfw044
Perkins RM, Chang AR, Wood KE, Coresh J, Matsushita K, Grams M. Incident chronic kidney disease: trends in management and outcomes. Clin Kidney J. 2016 Jun;9(3):432-7. doi: 10.1093/ckj/sfw044. Epub 2016 May 25. PMID: 27274830; PMCID: PMC4886925.
Copy Download .nbib Format: NLM
Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients.

Clinical kidney journal

Rosa-Diez G, Negri AL, Crucelegui MS, Philippi R, Perez-Teysseyre H, Sarabia-Reyes C, Loor-Navarrete H, Heguilen R.
PMID: 27274837
Clin Kidney J. 2016 Jun;9(3):481-5. doi: 10.1093/ckj/sfw021. Epub 2016 Apr 14.

BACKGROUND: Sevelamer has been associated with less progression of vascular calcifications. This effect could be due to a reduction in serum phosphate levels but also to other additive effects. Magnesium has been also shown to prevent vascular calcification but...

Cite
Rosa-Diez G, Negri AL, Crucelegui MS, et al. Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients. Clin Kidney J. 2016;9(3):481-5doi: 10.1093/ckj/sfw021.
Rosa-Diez, G., Negri, A. L., Crucelegui, M. S., Philippi, R., Perez-Teysseyre, H., Sarabia-Reyes, C., Loor-Navarrete, H., & Heguilen, R. (2016). Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients. Clinical kidney journal, 9(3), 481-5. https://doi.org/10.1093/ckj/sfw021
Rosa-Diez, Guillermo, et al. "Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients." Clinical kidney journal vol. 9,3 (2016): 481-5. doi: https://doi.org/10.1093/ckj/sfw021
Rosa-Diez G, Negri AL, Crucelegui MS, Philippi R, Perez-Teysseyre H, Sarabia-Reyes C, Loor-Navarrete H, Heguilen R. Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients. Clin Kidney J. 2016 Jun;9(3):481-5. doi: 10.1093/ckj/sfw021. Epub 2016 Apr 14. PMID: 27274837; PMCID: PMC4886916.
Copy Download .nbib Format: NLM
Atazanavir nephrotoxicity.

Clinical kidney journal

Hara M, Suganuma A, Yanagisawa N, Imamura A, Hishima T, Ando M.
PMID: 25815168
Clin Kidney J. 2015 Apr;8(2):137-42. doi: 10.1093/ckj/sfv015. Epub 2015 Mar 20.

Atazanavir is commonly used as one of the key drugs in combination antiretroviral therapy for human immunodeficiency virus (HIV). However, atazanavir has the potential to yield its crystalline precipitation in urine and renal interstitial tissues, leading to crystalluria, urolithiasis,...

Cite
Hara M, Suganuma A, Yanagisawa N, et al. Atazanavir nephrotoxicity. Clin Kidney J. 2015;8(2):137-42doi: 10.1093/ckj/sfv015.
Hara, M., Suganuma, A., Yanagisawa, N., Imamura, A., Hishima, T., & Ando, M. (2015). Atazanavir nephrotoxicity. Clinical kidney journal, 8(2), 137-42. https://doi.org/10.1093/ckj/sfv015
Hara, Masaki, et al. "Atazanavir nephrotoxicity." Clinical kidney journal vol. 8,2 (2015): 137-42. doi: https://doi.org/10.1093/ckj/sfv015
Hara M, Suganuma A, Yanagisawa N, Imamura A, Hishima T, Ando M. Atazanavir nephrotoxicity. Clin Kidney J. 2015 Apr;8(2):137-42. doi: 10.1093/ckj/sfv015. Epub 2015 Mar 20. PMID: 25815168; PMCID: PMC4370314.
Copy Download .nbib Format: NLM
The intestine and the kidneys: a bad marriage can be hazardous.

Clinical kidney journal

Vanholder R, Glorieux G.
PMID: 25815173
Clin Kidney J. 2015 Apr;8(2):168-79. doi: 10.1093/ckj/sfv004. Epub 2015 Feb 10.

The concept that the intestine and chronic kidney disease influence each other, emerged only recently. The problem is multifaceted and bidirectional. On one hand, the composition of the intestinal microbiota impacts uraemic retention solute production, resulting in the generation...

Cite
Vanholder R, Glorieux G. The intestine and the kidneys: a bad marriage can be hazardous. Clin Kidney J. 2015;8(2):168-79doi: 10.1093/ckj/sfv004.
Vanholder, R., & Glorieux, G. (2015). The intestine and the kidneys: a bad marriage can be hazardous. Clinical kidney journal, 8(2), 168-79. https://doi.org/10.1093/ckj/sfv004
Vanholder, Raymond, and Glorieux, Griet. "The intestine and the kidneys: a bad marriage can be hazardous." Clinical kidney journal vol. 8,2 (2015): 168-79. doi: https://doi.org/10.1093/ckj/sfv004
Vanholder R, Glorieux G. The intestine and the kidneys: a bad marriage can be hazardous. Clin Kidney J. 2015 Apr;8(2):168-79. doi: 10.1093/ckj/sfv004. Epub 2015 Feb 10. PMID: 25815173; PMCID: PMC4370304.
Copy Download .nbib Format: NLM
The curious right-sided predominance of peritoneal dialysis-related hydrothorax.

Clinical kidney journal

Guest S.
PMID: 25815179
Clin Kidney J. 2015 Apr;8(2):212-4. doi: 10.1093/ckj/sfu141. Epub 2015 Jan 06.

A known complication of peritoneal dialysis is the movement of dialysate into the pleural space, termed hydrothorax. Peritoneal dialysis-related hydrothorax is almost uniformly right-sided and represents one of many presentations of the porous diaphragm syndrome. In addition to diaphragm...

Cite
Guest S. The curious right-sided predominance of peritoneal dialysis-related hydrothorax. Clin Kidney J. 2015;8(2):212-4doi: 10.1093/ckj/sfu141.
Guest, S. (2015). The curious right-sided predominance of peritoneal dialysis-related hydrothorax. Clinical kidney journal, 8(2), 212-4. https://doi.org/10.1093/ckj/sfu141
Guest, Steven. "The curious right-sided predominance of peritoneal dialysis-related hydrothorax." Clinical kidney journal vol. 8,2 (2015): 212-4. doi: https://doi.org/10.1093/ckj/sfu141
Guest S. The curious right-sided predominance of peritoneal dialysis-related hydrothorax. Clin Kidney J. 2015 Apr;8(2):212-4. doi: 10.1093/ckj/sfu141. Epub 2015 Jan 06. PMID: 25815179; PMCID: PMC4370299.
Copy Download .nbib Format: NLM
Strategies for preserving residual renal function in peritoneal dialysis patients.

Clinical kidney journal

Nongnuch A, Assanatham M, Panorchan K, Davenport A.
PMID: 25815178
Clin Kidney J. 2015 Apr;8(2):202-11. doi: 10.1093/ckj/sfu140. Epub 2015 Jan 13.

Although there have been many advancements in the treatment of patients with chronic kidney disease (CKD) over the last 50 years, in terms of reducing cardiovascular risk, mortality remains unacceptably high, particularly for those patients who progress to stage...

Cite
Nongnuch A, Assanatham M, Panorchan K, et al. Strategies for preserving residual renal function in peritoneal dialysis patients. Clin Kidney J. 2015;8(2):202-11doi: 10.1093/ckj/sfu140.
Nongnuch, A., Assanatham, M., Panorchan, K., & Davenport, A. (2015). Strategies for preserving residual renal function in peritoneal dialysis patients. Clinical kidney journal, 8(2), 202-11. https://doi.org/10.1093/ckj/sfu140
Nongnuch, Arkom, et al. "Strategies for preserving residual renal function in peritoneal dialysis patients." Clinical kidney journal vol. 8,2 (2015): 202-11. doi: https://doi.org/10.1093/ckj/sfu140
Nongnuch A, Assanatham M, Panorchan K, Davenport A. Strategies for preserving residual renal function in peritoneal dialysis patients. Clin Kidney J. 2015 Apr;8(2):202-11. doi: 10.1093/ckj/sfu140. Epub 2015 Jan 13. PMID: 25815178; PMCID: PMC4370298.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1818 entries